Related Experiment Videos
Serum iron level in acute lymphoblastic leukaemia
Acta Paediatrica Academiae Scientiarum Hungaricae
|January 1, 1978
Summary
Serum iron levels (SIL) are linked to acute lymphoblastic leukemia activity in children. Higher SIL was seen in untreated patients, decreasing with treatment and remission, suggesting SIL
Area of Science:
- Pediatric Oncology
- Hematology
- Clinical Chemistry
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Monitoring disease activity and treatment response is crucial for managing ALL.
- Serum iron levels (SIL) have not been extensively studied as a biomarker in pediatric ALL.
Purpose of the Study:
- To investigate the relationship between serum iron levels (SIL) and the activity of acute lymphoblastic leukemia (ALL) in children.
- To determine if SIL can serve as an auxiliary marker in the management of pediatric ALL.
Main Methods:
- Serum iron levels (SIL) were measured using atomic absorption spectrophotometry.
- The study included 57 children diagnosed with acute lymphoblastic leukemia (ALL).
- SIL was analyzed in relation to disease status (untreated, during treatment, remission) and complications.
Main Results:
- Serum iron levels (SIL) varied significantly with the activity of acute lymphoblastic leukemia (ALL).
- Mean SIL was highest in untreated children with ALL.
- SIL decreased during treatment as myelograms normalized and further decreased during remission, especially with resolved organ localizations and infections.
Conclusions:
- Serum iron levels (SIL) correlate with the disease activity in pediatric acute lymphoblastic leukemia (ALL).
- SIL may serve as a valuable auxiliary test for monitoring ALL management in children.
- Changes in SIL reflect treatment response and disease remission status.